Literature DB >> 7076799

Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17 beta-estradiol in the human ovary.

R Demura, M Ono, H Demura, K Shizume, H Oouchi.   

Abstract

An ovarian perifusion technique was used to determine if there is a direct suppressive effect of PRL on human gonadal steroid secretion. Ovarian tissue from nine patients was examined. Ovine PRL (0.1-10 IU/ml) directly suppressed progesterone and 17 beta-estradiol secretion by human ovaries. hCG (1-10 IU/ml) stimulated both progesterone and 17 beta-estradiol secretion. Simultaneous administration of PRL (5-10 IU/ml) suppressed the stimulatory effect of hCG. The ovarian tissue obtained from a hyperprolactinemic patient did not respond to hCG. These results indicate that PRL inhibits both basal and gonadotropin-stimulated ovarian steroid secretion by human ovaries and that this may be one cause of the hypogonadism associated with hyperprolactinemia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076799     DOI: 10.1210/jcem-54-6-1246

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Prolactinoma through the female life cycle.

Authors:  Deirdre Cocks Eschler; Pedram Javanmard; Katherine Cox; Eliza B Geer
Journal:  Endocrine       Date:  2017-11-24       Impact factor: 3.633

Review 2.  Do nothing but observe microprolactinomas: when and how to replace sex hormones?

Authors:  Vivien Bonert
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

3.  Role of transient hyperprolactinemia in the late follicular phase of the gonadotropin-stimulated cycle.

Authors:  Shuji Takiguchi; Yasuhiko Nakamura; Yoshiaki Yamagata; Hisako Takayama; Ayako Harada; Norihiro Sugino; Hiroshi Kato
Journal:  Reprod Med Biol       Date:  2002-12-11

4.  Relationship of human oocyte maturity, fertilization, and cleavage to follicular fluid prolactin and steroids.

Authors:  M S Lee; Z Ben-Rafael; F Meloni; L Mastroianni; G L Flickinger
Journal:  J In Vitro Fert Embryo Transf       Date:  1987-06

5.  PRL Mutation Causing Alactogenesis: Insights Into Prolactin Structure and Function Relationships.

Authors:  Mika Moriwaki; Corrine K Welt
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 5.958

6.  Hyperprolactinaemia - a problem in patients from the reproductive period to the menopause.

Authors:  Sylwia Pałubska; Aneta Adamiak-Godlewska; Izabela Winkler; Katarzyna Romanek-Piva; Tomasz Rechberger; Marek Gogacz
Journal:  Prz Menopauzalny       Date:  2017-04-26

Review 7.  The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology.

Authors:  Renata S Auriemma; Guendalina Del Vecchio; Roberta Scairati; Rosa Pirchio; Alessia Liccardi; Nunzia Verde; Cristina de Angelis; Davide Menafra; Claudia Pivonello; Alessandro Conforti; Carlo Alviggi; Rosario Pivonello; Annamaria Colao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-09       Impact factor: 5.555

8.  Menstrual Cycle Abnormalities in Patients with Prolactinoma and Drug-induced Hyperprolactinemia.

Authors:  Bindu Kulshreshtha; Isha Pahuja; Deepak Kothari; Indu Chawla; Neera Sharma; Shikha Gupta; Anuja Mittal
Journal:  Indian J Endocrinol Metab       Date:  2017 Jul-Aug
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.